FDA.reportPublic FDA data

acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]

RxCUI
1101754
RxNorm name
acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
Display name
VANQUISH (Oral Pill)
Full name
acetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
Term type
SBD
Status
Active
Strength
194-227-33 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-07-17 21:40:19

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
062011
Active start
062011
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
aspirin227 MG / 1 EACHaspirinaspirin
acetaminophen194 MG / 1 EACHacetaminophenacetaminophen
caffeine33 MG / 1 EACHcaffeinecaffeine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
aspirin1191
acetaminophen161
caffeine1886

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm Nameacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm SynonymAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]NAMES
RxNorm SynonymVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral TabletNAMES
TTYSBDATTRIBUTES
SPL_SET_IDf879e8c7-1983-4a85-b87d-38f5068351fcCODES
RxCUI1101754CODES
MMSL_CODEBD36925CODES
MMSL_CODEBD4578CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
42364-0011-142364-0011vanquish acetaminophen, aspirin, and caffeineDSE Healthcare Solutions, LLCM013
42364-0011-242364-0011vanquish acetaminophen, aspirin, and caffeineDSE Healthcare Solutions, LLCM013

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01342364-0011vanquish acetaminophen, aspirin, and caffeineOTC MONOGRAPH DRUGDSE Healthcare Solutions, LLC

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
12843017148rxnav_ndcsyes
42364001101rxnav_ndcsyes
42364001102rxnav_ndcsyes
59556015110rxnav_ndcsyes
12843017144rxnav_historical
12843017146rxnav_historical
16864020101rxnav_historical
16864020102rxnav_historical
42364012203rxnav_historical
42364012206rxnav_historical
59556081006rxnav_historical
59556081011rxnav_historical
89411012201rxnav_historical

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral TabletSY6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]SY6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish 227 MG / 194 MG / 33 MG Oral TabletPSN6Vanquish Drug Facts20241218
f879e8c7-1983-4a85-b87d-38f5068351fcacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]SBD6Vanquish Drug Facts20241218

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
f879e8c7-1983-4a85-b87d-38f5068351fcVanquish Drug FactsDSE Healthcare Solutions, LLC20241218

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN02BEAnilidesATC1-4acetaminophen
ATCA01ADOther agents for local oral treatmentATC1-4aspirin
ATCD11AXOther dermatologicalsATC1-4caffeine
ATCB01ACPlatelet aggregation inhibitors excl. heparinATC1-4aspirin
ATCN02BASalicylic acid and derivativesATC1-4aspirin
ATCN06BCXanthine derivativesATC1-4caffeine
FDASPLD014970XanthinesCHEMhas_chemical_structurecaffeine
FDASPLN0000175739Central Nervous System StimulantEPChas_epccaffeine
FDASPLN0000175790MethylxanthineEPChas_epccaffeine
FDASPLN0000175722Nonsteroidal Anti-inflammatory DrugEPChas_epcaspirin
FDASPLN0000175578Platelet Aggregation InhibitorEPChas_epcaspirin
FDASPLN0000175729Central Nervous System StimulationPEhas_pecaffeine
MEDRTD000082AcetaminophenCHEMhas_ingredientacetaminophen
MEDRTD001241AspirinCHEMhas_ingredientaspirin
MEDRTD002110CaffeineCHEMhas_ingredientcaffeine
MEDRTD001049ApneaDISEASEmay_treatcaffeine
MEDRTD001172Arthritis, RheumatoidDISEASEmay_treataspirin
MEDRTD001778Blood Coagulation DisordersDISEASEci_withaspirin
MEDRTD001791Blood Platelet DisordersDISEASEci_withaspirin
MEDRTD002544Cerebral InfarctionDISEASEmay_preventaspirin
MEDRTD002644ChickenpoxDISEASEci_withaspirin
MEDRTD002675Child, PreschoolDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withacetaminophen
MEDRTD004342Drug HypersensitivityDISEASEci_withaspirin
MEDRTD004342Drug HypersensitivityDISEASEci_withcaffeine
MEDRTD005221FatigueDISEASEmay_treatcaffeine
MEDRTD005334FeverDISEASEmay_preventacetaminophen
MEDRTD005334FeverDISEASEmay_treataspirin
MEDRTD005334FeverDISEASEmay_treatacetaminophen
MEDRTD005955Glucosephosphate Dehydrogenase DeficiencyDISEASEci_withacetaminophen
MEDRTD006073GoutDISEASEmay_treataspirin
MEDRTD006396HematemesisDISEASEci_withaspirin
MEDRTD006474Hemorrhagic DisordersDISEASEci_withaspirin
MEDRTD007223InfantDISEASEci_withaspirin
MEDRTD007249InflammationDISEASEmay_treataspirin
MEDRTD002546Ischemic Attack, TransientDISEASEmay_preventaspirin
MEDRTD008107Liver DiseasesDISEASEci_withacetaminophen
MEDRTD008551MelenaDISEASEci_withaspirin
MEDRTD009203Myocardial InfarctionDISEASEmay_preventaspirin
MEDRTD009298Nasal PolypsDISEASEci_withaspirin
MEDRTD010003OsteoarthritisDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_treataspirin
MEDRTD010146PainDISEASEmay_preventacetaminophen
MEDRTD010146PainDISEASEmay_treatacetaminophen
MEDRTD010146PainDISEASEmay_preventaspirin
MEDRTD011225Pre-EclampsiaDISEASEmay_preventaspirin
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withaspirin
MEDRTD012213Rheumatic FeverDISEASEmay_treataspirin
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moaaspirin
MEDRTN0000000133Enzyme InhibitorsMOAhas_moacaffeine
MEDRTN0000000108Prostaglandin Receptor AntagonistsMOAhas_moaacetaminophen
MEDRTN0000008322BronchodilationPEhas_pecaffeine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pecaffeine
MEDRTN0000175724Central Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000008567Decreased Collecting Duct Water PermeabilityPEhas_pecaffeine
MEDRTN0000008831Decreased Platelet Activating Factor ProductionPEhas_peaspirin
MEDRTN0000008832Decreased Platelet AggregationPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peaspirin
MEDRTN0000008836Decreased Prostaglandin ProductionPEhas_peacetaminophen
MEDRTN0000009006Decreased Thromboxane ProductionPEhas_peaspirin
MEDRTN0000009072Hypothalamic Endocrine Activity AlterationPEhas_peacetaminophen
MEDRTN0000009197Increased Central Nervous System Organized Electrical ActivityPEhas_pecaffeine
MEDRTN0000175725Peripheral Nervous System Activity AlterationPEhas_peacetaminophen
MEDRTN0000000026Hepatic MetabolismPKhas_pkaspirin
MEDRTN0000000026Hepatic MetabolismPKhas_pkacetaminophen
MEDRTN0000000042Renal ExcretionPKhas_pkaspirin
MEDRTN0000000042Renal ExcretionPKhas_pkacetaminophen

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH194 MG / 227 MG / 33 MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD36925
CODESMMSL_CODEBD4578
CODESRxCUI1101754
CODESSPL_SET_IDf879e8c7-1983-4a85-b87d-38f5068351fc
NAMESPrescribable SynonymVanquish 227 MG / 194 MG / 33 MG Oral Tablet
NAMESRXNAV_STRAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm Nameacetaminophen 194 MG / aspirin 227 MG / caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm SynonymAPAP 194 MG / ASA 227 MG / Caffeine 33 MG Oral Tablet [Vanquish]
NAMESRxNorm SynonymVanquish (APAP 194 MG / ASA 227 MG / caffeine 33 MG) Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon